The 2025-2030 World Outlook for Genital Herpes Treatments - Image 1

Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Genital Herpes Treatments

Illnesses & Conditions

Out of Stock

Price data last checked 125 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 183 days. Could come back at any time — we're watching for you.

Out of stock 183 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 606 days • 606 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 606 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (606 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 606 days

Description

This study covers the world outlook for genital herpes treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of genital herpes treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, GlaxoSmithKline, Mylan NV, Novartis, and Sun Pharmaceuticals Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: Paperback
ASIN: B0CYDNYXDX
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 28 March 2024

The 2025-2030 World Outlook for Genital Herpes Treatments

Gone for 183 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

Human Herpesvirus-6: General Virology, Epidemiology, and Clinical Pathology (Volume 12) (Perspectives in Medical Virology, Volume 12)

Human Herpesviruses HHV-6A, HHV-6B & HHV-7: Diagnosis and Clinical Management: Volume 12 (Perspectives in Medical Virology, Volume 12)

Immunobiology and Prophylaxis of Human Herpesvirus Infections: 278 (Advances in Experimental Medicine and Biology, 278)

Herpes Simplex Virus: Methods and Protocols: 1144 (Methods in Molecular Biology, 1144)

Herpes Cure: A Research-Backed Guide to Healing Through Herbal Medicine - 2nd Edition (Vol-1) (Herpes Cure with Ayurvedic Protocol)

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology, 394)

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology, 394)

Alphaherpesviruses: Molecular Biology, Host Interactions and Control

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Human Herpesviruses: 1045 (Advances in Experimental Medicine and Biology, 1045)

Herpesviridae: Viral Structure, Life Cycle and Infections: Viral Structure, Life Cycle & Infections

Cell Biology of Herpes Viruses: 223 (Advances in Anatomy, Embryology and Cell Biology, 223)

Herpesvirus DNA: Recent studies on the organization of viral genomes, mRNA transcription, DNA replication, defective DNA, and viral DNA sequences in ... 1 (Developments in Molecular Virology, 1)

FROM THE HALLOWED HALLS OF HERPESVIROLOGY: A Tribute to Bernard Roizman

Biopharmaceutics and Drug Hypersensitivity (Pharmacology - Research, Safety Testing and Regulation)

Color Atlas of Herpetic Eye Disease: A Practical Guide to Clinical Management

Herpesviruses, the Immune System, and AIDS: 6 (Developments in Medical Virology, 6)

Mucocutaneous Manifestations of Viral Diseases: An Illustrated Guide to Diagnosis and Management

Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention

The 2023-2028 Outlook for Herpes Simplex Virus Infections in the United States

The 2023-2028 World Outlook for Herpes Simplex Virus Treatments

The 2023 Report on Herpes Simplex Virus Infections: World Market Segmentation by City

The 2023-2028 Outlook for Herpes Simplex Virus Infections in India